HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short-course antibiotic therapy for infections with a single causative pathogen.

Abstract
Studies evaluating short-course therapy have focused on prevalent infections with demonstrable aetiology. Metaanalyses of clinical trials demonstrate that uncomplicated acute otitis media in children can be successfully treated with a 5-day course of cefuroxime axetil. In the treatment of tonsillopharyngitis, 4 - 5-day courses of oral cephalosporins compared favourably with the standard 10-day penicillin V regimen. The clinical cure rate and the bacteriological eradication rate were both significantly higher for cephalosporins than for penicillin V. Bacteriological failure rates for cephalosporins were about half those for penicillin. In studies on acute bacterial exacerbations of chronic bronchitis, no difference in the clinical cure rates or relapse rates was found between short-course therapy using cephalosporins and standard courses. The short courses had the advantage of improved gastrointestinal tolerance compared with longer durations of treatment. The results suggest that new short-course dosing regimens are viable and may be favourable in terms of increased tolerability, reduction in healthcare costs, enhanced patient compliance and the control of the development of antibiotic resistance.
AuthorsD Adam
JournalThe Journal of international medical research (J Int Med Res) Vol. 28 Suppl 1 Pg. 13A-24A ( 2000) ISSN: 0300-0605 [Print] England
PMID11092226 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • Cefuroxime
  • cefuroxime axetil
Topics
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Bronchitis (drug therapy, microbiology)
  • Cefuroxime (administration & dosage, analogs & derivatives, therapeutic use)
  • Cephalosporins (administration & dosage, therapeutic use)
  • Drug Administration Schedule
  • Humans
  • Otitis Media (drug therapy)
  • Palatine Tonsil
  • Pharyngitis (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: